This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
H Abikoff , J McGough , B Vitiello , J McCracken , (2005) Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry 44:418–427.
G Aldurra , JW Crayton (2001) Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report. J Clin Psychopharmacol 21:343–344.
American Academy of Children and Adolescent Psychiatry (1998) Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 37:27S–45S.
American Academy of Children and Adolescent Psychiatry (2009) Practice parameter on the use of psychotropic medication in children and adolescents. J Am Acad Child Adolesc Psychiatry 48:961–973.
E Anagnostou , K Esposito , L Soorya , W Chaplin , (2006) Divalproex vs. placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. J Clin Psychopharmacol 26:444–446.
SW Andersen , DB Clemow , SA Corya (2005). Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder. J Clin Psychiatry 66:1468–1476.
DJ Belle , CS Ernest , JM Sauer , BP Smith , (2002). Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics. J Clin Pharmacol 42:1219–1227.
VS Bhatara , M Feil , K Hoagwood , B Vitiello , (2004). National trends in concomitant psychotropic medication with stimulants in pediatric visits: practice vs. knowledge. J Attent Disord 7:217–226.
J Biederman , E Mick , TJ Spencer , TE Wilens , (2000). Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 10:185–192.
B Birmaher , D Brent , W Bernet , O Bukstein , (2007). Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 46:1503–1526.
JC Blader , GA Carlson (2007). Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996–2004. Biol Psychiatry 62:107–114.
MH Bloch , A Landeros-Weisenberger , B Kelmendi , V Coric , (2006). A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11:622–632.
JA Bridge , S Iyengar , CB Salary , RP Barbe , (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. J Am Med Assoc 297:1683–1696.
CL Budman , M Sherling , RD Bruun (1995). Combined pharmacotherapy risk. J Am Acad Child Adolesc Psychiatry 34:263–264.
MS Burke , A Josephson , A Lightsey (1995). Combined methylphenidate and imipramine complication. J Am Acad Child Adolesc Psychiatry 34:403–404.
R Bussing , GM Levin (1993). Methamphetamine and fluoxetine treatment of a child with attention-deficit hyperactivity disorder and obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 3:53–58.
PH Caldwell , SB Murphy , PN Butow , JC Craig (2004). Clinical trials in children. Lancet 364:803–811.
AH Cheung , GJ Emslie , TL Mayes (2005). Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 46:735–754.
JS Comer , M Olfson , R Mojtabai (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007. J Am Acad Child Adolesc Psychiatry 49:1001–1010.
DF Connor , KR Ozbayrak , KA Kusiak , AB Caponi , (1997). Combined pharmacotherapy in children and adolescents in a residential treatment center. J Am Acad Child Adolesc Psychiatry 36:248–254.
CU Correll , HE Carlson (2006). Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 45:771–791.
M Coskun , S Zoroglu (2008). Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. J Clin Psychopharmacol 28:723–725.
EJ Costello , S Mustillo , A Erkanli , G Keeler , (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60:837–844.
NA Crossley , M Bauer (2007). Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry 68:935–940.
AR Curtis , RW Richards (2007). The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine. Ann Clin Psychiatry 19:199–200.
WB Daviss , P Bentivoglio , R Racusin , KM Brown , (2001). Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry 40:307–314.
AJ Dean , BM McDermott , RT Marshall (2006). Psychotropic medication utilization in a child and adolescent mental health service. J Child Adolesc Psychopharmacol 16:273–285.
C DeBattista , J Hawkins (2009). Utility of atypical antipsychotics in the treatment of resistant unipolar depression. CNS Drugs 23:369–377.
M de Wit , FJ Snoek (2011). Depressive symptoms and unmet psychological needs of Dutch youth with type 1 diabetes: results of a web-survey. Pediatr Diabetes 12:172–176.
S dosReis , JM Zito , DJ Safer , JF Gardner , (2005). Multiple psychotropic medication use for youths: a two-state comparison. J Child Adolesc Psychopharmacol 15:68–77.
B Dubicka , S Hadley , C Roberts (2006). Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry 189:393–398.
FF Duffy , WE Narrow , DS Rae , JC West , (2005). Concomitant pharmacotherapy among youths treated in routine psychiatric practice. J Child Adolesc Psychopharmacol 15:12–25.
HS Duggal , PC Pathak , CC Coleman (2003). Treating selective serotonin reuptake inhibitor-induced behavioral activation with valproate. J Child Adolesc Psychopharmacol 13:113–114.
ES Ercan , H Copkunol , S Cykoethlu , A Varan (2003). Olanzapine treatment of an adolescent girl with anorexia nervosa. Hum Psychopharmacol 18:401–403.
BH Esbjorn , M Hoeyer , J Dyrborg , I Leth , (2010). Prevalence and co-morbidity among anxiety disorders in a national cohort of psychiatrically referred children and adolescents. J Anxiety Disord 24:866–872.
CA Essau (2008). Comorbidity of depressive disorders among adolescents in community and clinical settings. Psychiatry Res 158:35–42.
A Faber , LT de Jong-van den Berg , PB van den Berg , H Tobi (2005). Psychotropic co-medication among stimulant-treated children in The Netherlands. J Child Adolesc Psychopharmacol 15:38–43.
SV Faraone , J Biederman , CP Morley , TJ Spencer (2008). Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 47:994–1009.
DJ Feeney , WM Klykylo (1997). Medication-induced seizures. J Am Acad Child Adolesc Psychiatry 36:1018–1019.
JM Fegert , M Kolch , JM Zito , G Glaeske , (2006). Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16:197–206.
Y Figueroa , DR Rosenberg , B Birmaher , MS Keshavan (1998). Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol 8:61–67.
RL Findling (1996). Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol 6:165–175.
RL Findling , J Lingler , BM Rowles , NK McNamara , (2008). A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity. J Child Adolesc Psychopharmacol 18:615–621.
KD Fitzgerald , CM Stewart , V Tawile , DR Rosenberg (1999). Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. J Child Adolesc Psychopharmacol 9:115–123.
CA Fontanella , JA Bridge , JV Campo (2009). Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients. Ann Pharmacother 43:1939–1947.
D Fraguas , CU Correll , J Merchan-Naranjo , M Rapado-Castro , (2011). Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol 21:621–645.
D Fraguas , J Merchan-Naranjo , C Arango (2010). Differential characteristics of the efficacy and tolerability of second-generation antipsychotics in the treatment of psychotic disorders in children and adolescents. Rev Psiquiat Salud Ment 3:152–167.
GD Gammon , TE Brown (1993). Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 3:1–10.
B Geller , R Tillman , K Bolhofner , B Zimerman (2010). Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord 12:164–171.
D Geller , C Donnelly , F Lopez , R Rubin , (2007). Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 46:1119–1127.
DA Geller , J Biederman , ED Reed , T Spencer , (1995). Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 34:36–44.
AK George , AR Kunwar , A Awasthi (2005). Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin. J Child Adolesc Psychopharmacol 15:693–695.
N Ghaziuddin , A Iqbal , S Khetarpal (2001). Myoclonus during prolonged treatment with sertraline in an adolescent patient. J Child Adolesc Psychopharmacol 11:199–202.
RD Gibbons , K Hur , DK Bhaumik , JJ Mann (2006). The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry 163:1898–1904.
CR Good (2006). Adjunctive quetiapine targets self-harm behaviors in adolescent females with major depressive disorder. J Child Adolesc Psychopharmacol 16:235–236.
J Graham , D Coghill (2008). Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. CNS Drugs 22:213–237.
TA Hammad , TP Laughren , JA Racoosin (2006). Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol 26:203–207.
S Hawkridge , DJ Stein , C Bouwer (1996). Combined pharmacotherapy for TS and OCD. J Am Acad Child Adolesc Psychiatry 35:703–704.
CW Hughes , GJ Emslie , ML Crismon , K Posner , (2007). Texas children's medication algorithm project: update from texas consensus conference panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry 46:667–686.
EM Hunkeler , B Fireman , J Lee , R Diamond , (2005). Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994–2003. J Child Adolesc Psychopharmacol 15:26–37.
EA Kastelic , MJ Labellarte , MA Riddle (2000). Selective serotonin reuptake inhibitors for children and adolescents. Curr Psychiatry Rep 2:117–123.
PC Kendall , SN Compton , JT Walkup , B Birmaher , (2010). Clinical characteristics of anxiety disordered youth. J Anxiety Disord 24:360–365.
B Kennard , S Silva , B Vitiello , J Curry , (2006). Remission and residual symptoms after short-term treatment in the treatment of adolescents with depression study (TADS). J Am Acad Child and Adolesc Psychiatry 45:1404–1411.
M Koelch , A Prestel , H Singer , F Keller , (2009). Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns. J Child Adolesc Psychopharmacol 19:756–770.
RA Kowatch , M Fristad , B Birmaher , KD Wagner , (2005). Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:213–235.
CJ Kratochvil , JH Newcorn , LE Arnold , D Duesenberg , (2005). Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry 44:915–924.
BP Kurtz , AN Abrams (2010). Psychiatric aspects of pediatric cancer. Child Adolesc Psychiatric Clin N Am 19:401–421.
K Larson , SA Russ , RS Kahn , N Halfon (2011). Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 127:462–470.
E Lee , AR Teschemaker , R Johann-Liang , G Bazemore , (2012). Off-label prescribing patterns of antidepressants in children and adolescents. Pharmacoepidemiol Drug Saf 21:137–144.
AM Libby , HD Orton , RJ Valuck (2009). Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry 66:633–639.
M Lopez-Larson , JA Frazier (2006). Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders. Harv Rev Psychiatry 14:285–304.
J Ma , KV Lee , RS Stafford (2005). Depression treatment during outpatient visits by U.S. children and adolescents. J Adolesc Health 37:434–442.
RS McIntyre , JM Jerrell (2009). Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study. J Clin Psychiatry 70:240–246.
S Mahapatra , JL Belgrad , MA Adeoye (2011). Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion. Pediatrics 127:e235–e238.
J Mancini , X Thirion , A Masut , C Saillard , (2006). Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. Pharmacoepidemiol Drug Saf 15:494–503.
A Martin , T Van Hoof , D Stubbe , T Sherwin , (2003). Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatr Serv 54:72–77.
G Masi , S Millepiedi , G Perugi , C Pfanner , (2009). Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study. CNS Drugs 23:241–252.
G Masi , G Perugi , S Millepiedi , C Toni , (2007). Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications. J Child Adolesc Psychopharmacol 17:475–486.
G Masi , C Pfanner , S Millepiedi , S Berloffa (2010). Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder. J Clin Psychopharmacol 30:688–693.
KR Merikangas , JP He , M Burstein , SA Swanson , (2010). Lifetime prevalence of mental disorders in U.S. adolescents: results from the national comorbidity survey replication–adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 49:980–989.
C Moreno , G Laje , C Blanco , H Jiang , (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 64:1032–1039.
C Moreno , J Merchan-Naranjo , M Alvarez , I Baeza , (2010). Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses. Bipolar Disord 12:172–184.
C Moreno , AM Roche , LL Greenhill (2006). Pharmacotherapy of child and adolescent depression. Child Adolesc Psychiatric Clin N Am 15:977–998.
S Nagar , JT Sherer , H Chen , RR Aparasu (2010). Extent of functional impairment in children and adolescents with depression. Curr Med Res Opin 26:2057–2064.
CB Nemeroff , A Kalali , MB Keller , DS Charney , (2007). Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 64:466–472.
M Olfson , D Shaffer , SC Marcus , T Greenberg (2003a). Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60:978–982.
M Olfson , MJ Gameroff , SC Marcus , PS Jensen (2003b). National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry 160:1071–1077.
M Olfson , SC Marcus , MM Weissman , PS Jensen (2002). National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 41:514–521.
O Oner , P Oner (2008). Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports. J Psychopharmacol 22:809–811.
T Owley , S Owley , B Leventhal , EH Cook Jr. (2002). Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder. J Child Adolesc Psychopharmacol 12:165–171.
O Ozcan , MA Selimoglu (2009). Self-injury behavior in an adolescent with Wilson's disease. Eur Child Adolesc Psychiatry 18:761–762.
D Padla (2001). Quetiapine resolves psychotic depression in an adolescent boy. J Child Adolesc Psychopharmacol 11:207–208.
YM Park , YK Jung (2010). Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression. Prog Neuropsychopharmacol Biol Psychiatry 34:719–720.
S Pathak , A Danielyan , RA Kowatch (2004). Successful treatment of trichotillomania with olanzapine augmentation in an adolescent. J Child Adolesc Psychopharmacol 14:153–154.
S Pathak , ES Johns , RA Kowatch (2005). Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series. J Child Adolesc Psychopharmacol 15:696–702.
SR Pliszka , ML Crismon , CW Hughes , CK Corners , (2006). The Texas children's medication algorithm project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:642–657.
J Puig-Antich , E Lukens , M Davies , D Goetz , (1985). Psychosocial functioning in prepubertal major depressive disorders. I. Interpersonal relationships during the depressive episode. Arch Gen Psychiatry 42:500–507.
R Raghavan , JC McMillen (2008). Use of multiple psychotropic medications among adolescents aging out of foster care. Psychiatr Serv 59:1052–1055.
E Reed , A Vance , E Luk , K Nunn (2004). Single and combined psychotropic medication use in a child and adolescent mental health service. Aust N Z J Psychiatry 38:204–211.
H Rittmannsberger (2002). The use of drug monotherapy in psychiatric inpatient treatment. Prog Neuropsychopharmacol Biol Psychiatry 26:547–551.
LM Robison , TL Skaer , DA Sclar , RS Galin (2002). Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants. CNS Drugs 16:129–137.
AJ Rush , MH Trivedi , JW Stewart , AA Nierenberg , (2011). Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 168:689–701.
JL Rushton , JT Whitmire (2001). Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 155:560–565.
PS Russell , C George , P Mammen (2006). Predictive factors for polypharmacy among child and adolescent psychiatry inpatients. Clin Pract Epidemiol Ment Health 2:25.
ND Ryan , V Meyer , S Dachille , D Mazzie , (1988). Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry 27:371–376.
DJ Safer , JM Zito (2006). Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children vs. adolescents. J Child Adolesc Psychopharmacol 16:159–169.
DJ Safer , JM Zito , S DosReis (2003). Concomitant psychotropic medication for youths. Am J Psychiatry 160:438–449.
FR Sallee , CL DeVane , RE Ferrell (2000). Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency. J Child Adolesc Psychopharmacol 10:27–34.
M Schertz , T Steinberg (2008). Seizures induced by the combination treatment of methylphenidate and sertraline. J Child Adolesc Psychopharmacol 18:301–303.
E Schirm , H Tobi , JM Zito , LT de Jong-van den Berg (2001). Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:E25.
TL Skaer , DA Sclar , LM Robison (2009). Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: an assessment of accordance with treatment recommendations from the American academy of child and adolescent psychiatry. Clin Ther 31:1478–1487.
SA Smathers , JG Wilson , MA Nigro (2003). Topiramate effectiveness in Prader–Willi syndrome. Pediatr Neurol 28:130–133.
A Sourander (2004). Combined psychopharmacological treatment among child and adolescent inpatients in Finland. Eur Child Adolesc Psychiatry 13:179–184.
RK Srivastava , S Sharma , N Tiwari , B Saluja (2005). Olanzapine augmentation of fluoxetine in trichotillomania: two cases. Aust N Z J Psychiatry 39:112–113.
JA Staller , MJ Wade , M Baker (2005). Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York. J Child Adolesc Psychopharmacol 15:57–61.
EA Storch , LJ Merlo , MJ Larson , WE Marien , (2008). Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr Psychiatry 49:35–42.
M Strober , R Freeman , J Rigali , S Schmidt , (1992). The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. J Am Acad Child Adolesc Psychiatry 31:16–20.
PH Thomsen (2004). Risperidone augmentation in the treatment of severe adolescent OCD in SSRI-refractory cases: a case-series. Ann Clin Psychiatry 16:201–207.
PH Thomsen , HU Mikkelsen (1999). The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases. Eur Child Adolesc Psychiatry 8:143–148.
KJ Took , BJ Buck (1996). Enuresis with combined risperidone and SSRI use. J Am Acad Child Adolesc Psychiatry 35:840–841.
T Usala , A Clavenna , A Zuddas , M Bonati (2008). Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur Neuropsychopharmacol 18:62–73.
E Vieta , J Locklear , O Gunther , M Ekman , (2010). Treatment options for bipolar depression: a systematic review of randomized, controlled trials. J Clin Psychopharmacol 30:579–590.
B Vitiello (2008). An international perspective on pediatric psychopharmacology. Int Rev Psychiatry 20:121–126.
KD Wagner , P Ambrosini , M Rynn , C Wohlberg , (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. J Am Med Assoc 290:1033–1041.
KD Wagner , AS Robb , RL Findling , J Jin , (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 161:1079–1083.
G Walter , B Lyndon , R Kubb (1998). Lithium augmentation of venlafaxine in adolescent major depression. Aust N Z J Psychiatry 32:457–459.
AM Wehr , LB Namerow (2001). Citalopram for OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 40:740–741.
N Weintrob , D Cohen , Y Klipper-Aurbach , Z Zadik , (2002). Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 156:696–701.
J Wijkstra , J Lijmer , FJ Balk , JR Geddes , (2006). Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis. Br J Psychiatry 188:410–415.
TE Wilens , J Biederman , A Kwon , R Chase , (2004). A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol 13:143–152.
JM Zito , DJ Safer , LT de Jong-van den Berg , K Janhsen , (2008). A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2:26.
JM Zito , DJ Safer , S DosReis , JF Gardner , (2002). Rising prevalence of antidepressants among US youths. Pediatrics 109:721–727.
JM Zito , H Tobi , LT de Jong-van den Berg , JM Fegert , (2006). Antidepressant prevalence for youths: a multi-national comparison. Pharmacoepidemiol Drug Saf 15:793–798.